Pharmaceutical Group and CEO facing adverse press from past convictions and FDA Investigations
A US-based pharmaceutical group is seeking our assistance in diminishing the visibility of news articles referencing the group's prior conviction for smuggling counterfeit antibiotics into the United States and their involvement in past investigations conducted by the FDA's Office of Criminal Investigations and the U.S. Customs Service for conspiracy, money laundering, and counterfeiting.
What we’ve done
Mapping all URLs that reference the client in connection with the court case.
Implementing a strategy designed to diminish the visibility of these references, safeguarding the client’s reputation, and ensuring a more positive online presence.
Formulating removal strategies while considering court case citation protocols within the legal frameworks of different countries and their corresponding local Information Acts.
Engaging in rigorous negotiations to secure the removal of the former CEO’s name from news items.
Negotiating with online platforms to remove obsolete information and uphold the right to be forgotten and rehabilitation.
Implementing removal strategies to secure the removal of the company’s name from these websites, using original and proprietary methods.
